Oregon Cancer

Providence Cancer Institute of Oregon announces new division director and deputy director of Hematology and Medical Oncology.

For Gynecologic Cancer Awareness Month, Providence Cancer Institute highlights a clinical trial that evaluates the safety and effectiveness of a new oral treatment for grade 1 endometrial cancer.

New trial open at Earle A. Chiles Research Institute, a division of Providence Cancer Institute of Oregon, is enrolling patients with advanced or metastatic solid tumors or non-Hodgkin lymphoma.

A phase II trial tests FOLFOX or CAPOX versus FOLFIRINOX in patients with locally advanced rectal cancer, and a phase I trial evaluates TBio-4101 in patients with advanced solid tumors.

Final outcomes from a Providence Cancer Institute-sponsored phase Ib trial evaluating pembrolizumab with either weekly paclitaxel or flat-dose capecitabine in treating patients with metastatic TNBC.

Researchers from Earle A. Chiles Research Institute, a division of Providence Cancer Institute of Oregon, shared their investigations to advance cancer research and treatments at the premier event.

Portland painter credits the support of Providence providers and creating art for helping her recover and heal from breast cancer and the loss of her mother.

Virtual talks at Providence highlight MRI-guided radiation therapy for treating breast cancer, pancreatic cancer treatments, and sexual health during and after ovarian cancer.

New investigator-initiated trial at Providence to evaluate a triple combination of medications for treating melanoma, and two new studies evaluating medication combinations to treat AML.

Providence researchers awarded an R21 grant from the National Institutes of Health which provides funding for projects with potential to significantly advance biomedical research.

A free virtual online class hosted by Providence Cancer Institute will highlight what to eat during cancer treatments, how to manage side effects and how to speed healing.

Physician scientist Sasha Stanton, M.D., Ph.D., shares her career journey to medical oncology and breast cancer research at Providence Cancer Institute.

Cancer survivor Jeff Newell shares his experiences as a volunteer at Providence Cancer Institute and how he uses his own cancer journey to impart hope to others.

Studies open at Providence Cancer Institute in Oregon for patients with head and neck cancer and patients with breast cancer that has metastasized in the brain.

World class cancer-care is coming even closer to home for Clackamas County residents. Providence Willamette Falls Medical Center is now serving patients at the Carol Daniel Suzuki Cancer Center.

In honor of Doctors' Day on March 30, we recognize the significant contributions of physicians and their commitment to providing the most advanced, highest quality care for our cancer patients.

New trials available at Earle A. Chiles Research Institute for patients with human epidermal growth factor receptor 2 positive (HER2+) colorectal cancer and patients with cholangiocarcinoma.

In honor of Social Work Month we recognize the incredible contributions of oncology social workers.

A new trial offered at Providence Cancer Institute is enrolling patients with early-stage HR-positive and HER2-negative breast cancer.